Dosing Begins in Phase 3 IgA Nephropathy Clinical Trial

According to a story from BioSpace, the biopharmaceutical company Retrophin, Inc., recently announced that the first patient has been treated in the company's Phase 3 clinical trial testing sparsentan as…

Continue Reading Dosing Begins in Phase 3 IgA Nephropathy Clinical Trial

Lee Cooper’s Take on IVF+PGT: A Way to Prevent all Fatal Genetic Conditions such as Spinal Muscular Atrophy Type 1?

What if you could prevent all of the world's most fatal genetic diseases? According to Lee D. Cooper, there's a way- we're just not educating people on how to do…

Continue Reading Lee Cooper’s Take on IVF+PGT: A Way to Prevent all Fatal Genetic Conditions such as Spinal Muscular Atrophy Type 1?
Opinion: It’s Pretty Obvious That Hospitals Are Overcharging For Just About Everything
1662222 / Pixabay

Opinion: It’s Pretty Obvious That Hospitals Are Overcharging For Just About Everything

The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of Patient Worthy. According to a story from Vox, a review of over…

Continue Reading Opinion: It’s Pretty Obvious That Hospitals Are Overcharging For Just About Everything

Interim Results from Phase 2a Trial for Nontuberculous Mycobacterial Lung Disease Bring Hope

Nontuberculous mycobacterial (NTM) lung infection occurs when someone inhales nontuberculous mycobacteria from the environment. There are various types of this bacteria, giving NTM different forms. But in all types of NTM,…

Continue Reading Interim Results from Phase 2a Trial for Nontuberculous Mycobacterial Lung Disease Bring Hope